Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Equity (2016 - 2025)

CorMedix (CRMD) has disclosed Return on Equity for 12 consecutive years, with 0.42% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 40.0% to 0.42% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.42% through Dec 2025, up 40.0% year-over-year, with the annual reading at 0.67% for FY2025, N/A changed from the prior year.
  • Return on Equity hit 0.42% in Q4 2025 for CorMedix, down from 0.61% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.61% in Q3 2025 to a low of 0.95% in Q2 2024.
  • Historically, Return on Equity has averaged 0.34% across 5 years, with a median of 0.49% in 2022.
  • Biggest five-year swings in Return on Equity: fell -26bps in 2021 and later surged 139bps in 2025.
  • Year by year, Return on Equity stood at 0.46% in 2021, then fell by -17bps to 0.53% in 2022, then dropped by -13bps to 0.6% in 2023, then skyrocketed by 103bps to 0.02% in 2024, then surged by 2540bps to 0.42% in 2025.
  • Business Quant data shows Return on Equity for CRMD at 0.42% in Q4 2025, 0.61% in Q3 2025, and 0.42% in Q2 2025.